
A new license to adapt EORTC questionnaires into electronic versions
15 Apr 2021

Surviving glioblastoma? EORTC Brain Tumour Group explores the factors that contribute to long-term survival
23 Mar 2021

European Stakeholder Group Statement – Maintaining the exchange of critical health data
15 Mar 2021

Long-term results from MINDACT trial confirm importance of gene expression signature in choosing breast cancer patients who can be spared chemotherapy
13 Mar 2021

New statement to replace the FDA 1572 form for non-IND trials supported by NCI
23 Feb 2021

PRESS RELEASE: Generating recommendations for the design, analysis and interpretation of patient- reported outcome (PRO) data for cancer clinical trials: the launch of SISAQOL-IMI
17 Feb 2021

When will the EU take treatment optimisation seriously?
15 Feb 2021

EORTC embarked on a membership renewal programme
5 Feb 2021